NO20012719L - Preparat med forbedret terapeutisk bredde, inneholdende nukleotidsynteseinhibitorer - Google Patents

Preparat med forbedret terapeutisk bredde, inneholdende nukleotidsynteseinhibitorer

Info

Publication number
NO20012719L
NO20012719L NO20012719A NO20012719A NO20012719L NO 20012719 L NO20012719 L NO 20012719L NO 20012719 A NO20012719 A NO 20012719A NO 20012719 A NO20012719 A NO 20012719A NO 20012719 L NO20012719 L NO 20012719L
Authority
NO
Norway
Prior art keywords
preparation
synthesis inhibitors
improved therapeutic
containing nucleotide
nucleotide synthesis
Prior art date
Application number
NO20012719A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012719D0 (no
Inventor
Juergen Lindner
Burkhard Haase
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20012719D0 publication Critical patent/NO20012719D0/no
Publication of NO20012719L publication Critical patent/NO20012719L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20012719A 1998-12-10 2001-06-01 Preparat med forbedret terapeutisk bredde, inneholdende nukleotidsynteseinhibitorer NO20012719L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19857009A DE19857009A1 (de) 1998-12-10 1998-12-10 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren
PCT/EP1999/009380 WO2000033876A1 (de) 1998-12-10 1999-12-01 Zubereitung mit verbesserter therapeutischer breite, enthaltend nukleotidsyntheseinhibitoren

Publications (2)

Publication Number Publication Date
NO20012719D0 NO20012719D0 (no) 2001-06-01
NO20012719L true NO20012719L (no) 2001-06-01

Family

ID=7890633

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012719A NO20012719L (no) 1998-12-10 2001-06-01 Preparat med forbedret terapeutisk bredde, inneholdende nukleotidsynteseinhibitorer

Country Status (30)

Country Link
EP (1) EP1137438B1 (es)
JP (1) JP2002531525A (es)
KR (1) KR20010080729A (es)
CN (1) CN1189214C (es)
AR (1) AR021577A1 (es)
AT (1) ATE218370T1 (es)
AU (1) AU766810B2 (es)
BG (1) BG105548A (es)
BR (1) BR9916006A (es)
CA (1) CA2354266A1 (es)
CZ (1) CZ20012029A3 (es)
DE (2) DE19857009A1 (es)
DK (1) DK1137438T3 (es)
EA (1) EA005136B1 (es)
EE (1) EE200100305A (es)
ES (1) ES2178496T3 (es)
HK (1) HK1041598B (es)
HR (1) HRP20010429A2 (es)
HU (1) HUP0104624A3 (es)
IL (1) IL143586A0 (es)
MX (1) MXPA01005861A (es)
NO (1) NO20012719L (es)
NZ (1) NZ511882A (es)
PL (1) PL349336A1 (es)
PT (1) PT1137438E (es)
SI (1) SI1137438T1 (es)
SK (1) SK284842B6 (es)
WO (1) WO2000033876A1 (es)
YU (1) YU39901A (es)
ZA (1) ZA200104815B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10112924A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate
JP4382354B2 (ja) * 2001-03-13 2009-12-09 ヴァルブルク・グリコムド・ゲーエムベーハー 1−ブタン酸誘導体およびその使用
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
JP2005538165A (ja) 2002-09-06 2005-12-15 シェボ ビオテック アクティエン ゲゼルシャフト 解糖酵素及び/又はアミノ基転移酵素錯体調節用化合物
JPWO2005060980A1 (ja) * 2003-12-24 2007-12-13 正彬 少名子 疾患治療用医薬及び糖尿病治療用医薬
DE102005017592A1 (de) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
EA015952B1 (ru) 2007-05-03 2011-12-30 Пфайзер Лимитед 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
ES2079765T3 (es) * 1991-10-23 1996-01-16 Hoechst Ag Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
IT1254519B (it) * 1992-03-16 1995-09-25 Chiesi Farma Spa Associazioni di composti ad attivita' antivirale
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
AU4596097A (en) * 1996-09-26 1998-04-17 Williams, James W. Improved therapeutic uses of 4-quinoline-carboxylic acid derivatives

Also Published As

Publication number Publication date
PL349336A1 (en) 2002-07-15
KR20010080729A (ko) 2001-08-22
DE59901681D1 (de) 2002-07-11
HRP20010429A2 (en) 2002-06-30
NO20012719D0 (no) 2001-06-01
SK7882001A3 (en) 2001-12-03
EE200100305A (et) 2002-08-15
EA005136B1 (ru) 2004-12-30
HUP0104624A2 (hu) 2002-04-29
DE19857009A1 (de) 2000-06-15
HK1041598B (zh) 2005-07-15
NZ511882A (en) 2003-11-28
EP1137438A1 (de) 2001-10-04
HUP0104624A3 (en) 2002-12-28
SK284842B6 (sk) 2005-12-01
AR021577A1 (es) 2002-07-24
IL143586A0 (en) 2002-04-21
EP1137438B1 (de) 2002-06-05
YU39901A (sh) 2005-06-10
JP2002531525A (ja) 2002-09-24
AU766810B2 (en) 2003-10-23
BG105548A (en) 2001-12-29
BR9916006A (pt) 2001-09-04
AU1779300A (en) 2000-06-26
WO2000033876A1 (de) 2000-06-15
CA2354266A1 (en) 2000-06-15
CZ20012029A3 (cs) 2002-02-13
MXPA01005861A (es) 2002-03-27
ES2178496T3 (es) 2002-12-16
DK1137438T3 (da) 2002-10-14
SI1137438T1 (en) 2002-08-31
CN1189214C (zh) 2005-02-16
ZA200104815B (en) 2002-06-13
CN1329506A (zh) 2002-01-02
PT1137438E (pt) 2002-11-29
ATE218370T1 (de) 2002-06-15
HK1041598A1 (en) 2002-07-12
EA200100647A1 (ru) 2001-12-24

Similar Documents

Publication Publication Date Title
DK1087943T3 (da) Terapeutiske biarylderivater
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
DE69937455D1 (de) Cyano-substituierte amidsalze
DE60010448D1 (de) Amid-derivate
IS5860A (is) 4,4-bíarýlpíperidín afleiður með ópíóíð viðtaka virkni
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20005399L (no) Farmasöytisk preparat
DE60025890D1 (de) Verbesserter Druckkopf
NO20013684D0 (no) Substituerte fenetylaminderivater
NO20012719L (no) Preparat med forbedret terapeutisk bredde, inneholdende nukleotidsynteseinhibitorer
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20011313D0 (no) Nytt preparat
DE59912172D1 (de) Doppelsiebformer
FI990662A (fi) Palkki
DE50007117D1 (de) Doppelsiebformer
FI991460A0 (fi) Parannettu Ca-N-P-liuoslannoite
SE9802294D0 (sv) ADH7 nucleotides
ITPE990016V0 (it) Gancio-ombrello per bicicletta
IT1304826B1 (it) Bicicletta per uso terapeutico.
SE9800864D0 (sv) New nucleotide sequences
SE9802575D0 (sv) New nucleotide sequences
IT1308928B1 (it) Tostatore per bruschette
IT1298572B1 (it) Bustina per infusione
LV12068A (lv) Kasete megenem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application